In this study, we designed an accurate and reliable pyrosequencing assay to determine the EGFR mutation in 494 NSCLC patients and the KRAS mutation in 1099 CRC patients of Chinese ethnicity. This evidence concerns the gene EGFR and non-small cell lung carcinoma.